With an initial investment of over 17 million euros for the development of 5,600 square meters of new laboratories dedicated to pharmaceutical technology and analytical chemistry, Alfasigma confirms its commitment to Research and Development. L’inauguration of ‘Labio 4.0 Marino Golinelli’, this morning in the Pomezia pharmaceutical group plant, is part of a broader corporate strategy of progressive investment in R&D, which allows Alfasigma, one of the top five pharmaceutical companies with Italian capital, to stand out both nationally and internationally for innovation and technological development.
Read Also
- Charles and Camilla unsettling : they go out for the first time in the containment for the ceremonies of May 8, May 8, 2020
- Mayotte: Emmanuel Macron promises “a security response as soon as possible” Nov 24, 2022
- Cs will present a motion in the town councils of the Region to give the Mar Menor legal personality Aug 18, 2021
- Leisure supersedes the family as the main source of outbreaks Jul 11, 2021
- Vincent Desagnat : who is his partner Matilda Vernon ? Jun 3, 2020
- Malcolm’s son? Frankie Muniz announced that she is expecting her first child Sep 27, 2020
- Orpea case: Why were several establishments of the group raided? Nov 16, 2022